Abstract: A system may include a mobile application residing on an external device and an inhalation device. The inhalation device may include a mouthpiece, a mouthpiece cover, medicament, and an electronics module comprising a processor. The inhalation device may be configured to both prepare a dose of medicament for delivery to a user and cause the processor to transition between power states when the mouthpiece cover is moved from a closed position to an open position to expose the mouthpiece. The electronics module or the mobile application may be configured to generate usage events based on usage of the inhalation device by the user. The electronics module may also include a pressure sensor, and the electronics module or the mobile application may be configured to determine whether a usage event is a good inhalation event, a fair inhalation event, or a no inhalation event based on feedback from the pressure sensor.

Abstract: A device for delivering medication to a user may include a main body, an electronics module, and a slider. The main body may include a mouthpiece, a medication reservoir, and a mouthpiece cover, where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.

Abstract: A system may include a mobile application residing on an external device and an inhalation device. The inhalation device may include a mouthpiece, a mouthpiece cover, medicament, and an electronics module comprising a processor. The inhalation device may be configured to both prepare a dose of medicament for delivery to a user and cause the processor to transition between power states when the mouthpiece cover is moved from a closed position to an open position to expose the mouthpiece. The electronics module or the mobile application may be configured to generate usage events based on usage of the inhalation device by the user. The electronics module may also include a pressure sensor, and the electronics module or the mobile application may be configured to determine whether a usage event is a good inhalation event, a fair inhalation event, or a no inhalation event based on feedback from the pressure sensor.

Abstract: A system may include a mobile application residing on an external device and an inhalation device. The inhalation device may include a mouthpiece, a mouthpiece cover, medicament, and an electronics module comprising a processor. The inhalation device may be configured to both prepare a dose of medicament for delivery to a user and cause the processor to transition between power states when the mouthpiece cover is moved from a closed position to an open position to expose the mouthpiece. The electronics module or the mobile application may be configured to generate usage events based on usage of the inhalation device by the user. The electronics module may also include a pressure sensor, and the electronics module or the mobile application may be configured to determine whether a usage event is a good inhalation event, a fair inhalation event, or a no inhalation event based on feedback from the pressure sensor.

Abstract: A device for delivering medication to a user may include a main body, an electronics module, and a slider. The main body may include a mouthpiece, a medication reservoir, and a mouthpiece cover, where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.

Abstract: A device for delivering medication to a user may include a main body, an electronics module, and a slider. The main body may include a mouthpiece, a medication reservoir, and a mouthpiece cover, where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.

Abstract: A system may include a mobile application residing on an external device and an inhalation device. The inhalation device may include a mouthpiece, a mouthpiece cover, medicament, and an electronics module comprising a processor. The inhalation device may be configured to both prepare a dose of medicament for delivery to a user and cause the processor to transition between power states when the mouthpiece cover is moved from a closed position to an open position to expose the mouthpiece. The electronics module or the mobile application may be configured to generate usage events based on usage of the inhalation device by the user. The electronics module may also include a pressure sensor, and the electronics module or the mobile application may be configured to determine whether a usage event is a good inhalation event, a fair inhalation event, or a no inhalation event based on feedback from the pressure sensor.

Abstract: A device for delivering medication to a user may include a main body, an electronics module, and a slider. The main body may include a mouthpiece, a medication reservoir, and a mouthpiece cover, where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.

Abstract: A device for delivering medication to a user may include a main body, an electronics module, and a slider. The main body may include a mouthpiece, a medication reservoir, and a mouthpiece cover, where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.

Abstract: A device for delivering medication to a user may include a main body, an electronics module, and a slider. The main body may include a mouthpiece, a medication reservoir, and a mouthpiece cover, where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.

Abstract: A method of obtaining a measurement of the extent of telangectasia in an area of skin is disclosed. Initially (S3-1) an image of an area of skin (2) to be analyzed is obtained. The obtained image is then processed (S3-2-S3-3) to determine blood distribution data indicative of the distribution of blood in an imaged area of skin. This blood distribution data is then converted (S3-5) using a Discrete Fourier Transform and the converted blood distribution data is then processed to obtain a measurement of the extent features in a determined distribution of blood correspond to structures of a predetermined size. The obtained measurement of the extent of telangectasia can then be combined (s3-6) with other measurements of the effects of photo-damage such as measurements of melanin disorder and collagen degradation to obtain a measurement of the extent of photo-damage.

Abstract: Method of analysing at least one parameter of a body component is provided. The method includes illuminating the component or body with light of at least a first and second waveband, receiving light of at least said first and second wavebands remitted by the component at a photoreceptor or photoreceptors, and analysing the light received at the photoreceptor(s) to provide a ratio between the amount of light remitted of the first waveband and the amount of light remitted of the second waveband, and from this calculating the component parameter.

Abstract: An image of an individual (2) is obtained using a digital camera (1). The image data is then processed by ratio determination module (10) and an image conversion module (12) to analyze the image and determine data representative of the distribution of blood and melanin in the skin of the imaged individual. This chromophore distribution data is then processed by an image generation module (18) which generates an image representative of the expected appearance of epithelial tissue having the determined distribution of chromophores where the epithelial tissue is under fixed illumination and has a flat spatial geometry and where all the identified melanin is present solely in the epidermis.

Abstract: An image of an individual (2) is obtained via a digital camera (1). The RGB image data is then processed to derive from the image data data representative of the distribution of chromophores resulting in the appearance of the individual (2). A calculated chromophore distribution is then utilised to derive a revised chromophore distribution representing the effect of the desired cosmetic or surgical intervention or medical condition. This chromophore distribution is then processed to generate an output image (34) illustrating the expected result of that intervention. The generated image (34) can be displayed simultaneously with an original image (33) so that the extent of expected improvement can be determined.

Abstract: Apparatus for monitoring the presence of one or more chromophores in a tissue sample, comprises a light source for projecting light to illuminate an area of such tissue sample, a photo-receptor for receiving light remitted by the illuminated area of tissue, and spectroscopic analyzer means for monitoring the remitted light, a comparator having means for comparing variations in the intensity and spectral characteristics of the remitted light with respect to the intensity and spectral characteristics of the projected light at different wavelengths and with a record of the intensity and spectral characteristics of light remitted by a reference sample of such tissue and means for emitting a control signal in response to any such variations. Methods of analyzing tissue histology, especially skin histology, are discussed, and a mathematical model is proposed for the analysis and comparison of the remitted light with a reference sample.

Abstract: A method of obtaining a measurement of the extent of telangectasia in an area of skin is disclosed. Initially (S3-1) an image of an area of skin (2) to be analyzed is obtained. The obtained image is then processed (S3-2-S3-3) to determine blood distribution data indicative of the distribution of blood in an imaged area of skin. This blood distribution data is then converted (S3-5) using a Discrete Fourier Transform and the converted blood distribution data is then processed to obtain a measurement of the extent features in a determined distribution of blood correspond to structures of a predetermined size. The obtained measurement of the extent of telangectasia can then be combined (s3-6) with other measurements of the effects of photo-damage such as measurements of melanin disorder and collagen degradation to obtain a measurement of the extent of photo-damage.

Abstract: A camera (1) is provided which is operable to obtain a RGB and infra-red image of an area of illuminated skin (2). The obtained image is then passed to a computer (8) which determines the manner in which light returned by points on the surface of the illuminated area of skin (2) appearing in the obtained image varies due to variations in lighting intensity and surface geometry. The infra-red channel of the obtained image is then normalized on the basis of the determined variations and a measurement of collagen thickness can then be determined utilizing the processed infra-red channel of the obtained image. The determination of variations in intensities of light returned by points on the surface of the illuminated area of skin (2) can be achieved by processing an obtained image to generate a 3-D model of the surface being imaged and using the 3-D model to select and process pre-stored lighting level data.

Abstract: Among various methods, apparatuses, and media, recording media having executable instructions are provided for measuring skin surface texture. One such execution of instructions can process an obtained first measurement of light utilising a model of the interactions of light with chromophores present in skin to determine variations in returned light levels arising due to variations in levels of illumination. Execution of such instructions can utilise a difference between the obtained first, and an obtained second measurement of light returned by an illuminated area of the skin and determined variations in returned light levels arising due to variations in levels of illumination, to obtain a measurement of the surface texture of the illuminated area of the skin.

Abstract: Images of a first and a second area of skin of an individual are obtained wherein one of said first and second areas of skin comprises an area of skin of the individual generally not exposed to sunlight. The images are then processed to determine the concentration and distribution of one or more chromophores in the imaged areas of skin. A relative measure of skin damage is then calculated using the determined of concentrations and distributions of chromophores in said imaged areas of skin. The calculated measure for an area of skin can be based upon determined co-variances for the distribution of chromophores in the sampled areas. Differences between measurements for exposed and unexposed areas of skin provide the relative measure of sun damage.

Abstract: An image of an individual (2) is obtained via a digital camera (1). The RGB image data is then processed to derive from the image data data representative of the distribution of chromophores resulting in the appearance of the individual (2). A calculated chromophore distribution is then utilised to derive a revised chromophore distribution representing the effect of the desired cosmetic or surgical intervention or medical condition. This chromophore distribution is then processed to generate an output image (34) illustrating the expected result of that intervention. The generated image (34) can be displayed simultaneously with an original image (33) so that the extent of expected improvement can be determined.